BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galbraith JW, Anderson ES, Hsieh YH, Franco RA, Donnelly JP, Rodgers JB, Schechter-Perkins EM, Thompson WW, Nelson NP, Rothman RE, White DAE. High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments - Birmingham, Oakland, Baltimore, and Boston, 2015-2017. MMWR Morb Mortal Wkly Rep 2020;69:569-74. [PMID: 32407307 DOI: 10.15585/mmwr.mm6919a1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lloyd M, Ransom EM, Anderson NW, Farnsworth CW. Evaluation of Infectious Disease Test Ordering and Positivity Rates in Illicit Fentanyl Users. J Appl Lab Med 2021;6:79-92. [PMID: 33313803 DOI: 10.1093/jalm/jfaa194] [Reference Citation Analysis]
2 Misa NY, Perez B, Basham K, Fisher-Hobson E, Butler B, King K, White DAE, Anderson ES. Racial/ethnic disparities in COVID-19 disease burden & mortality among emergency department patients in a safety net health system. Am J Emerg Med 2021;45:451-7. [PMID: 33039228 DOI: 10.1016/j.ajem.2020.09.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
3 Goodman S, Zahn M, Bruckner T, Boden-Albala B, Lakon CM. Measuring Hazards of Undetectable Viral Load among Hepatitis C Antibody Positive Residents of a Large Southern California County. Health Serv Res Manag Epidemiol 2021;8:23333928211066181. [PMID: 34926722 DOI: 10.1177/23333928211066181] [Reference Citation Analysis]
4 Sims OT, Truong DN, Wang K, Melton PA, Atim K. Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center. J Racial Ethn Health Disparities 2021. [PMID: 34254269 DOI: 10.1007/s40615-021-01105-5] [Reference Citation Analysis]
5 Park JS, Wong J, Cohen H. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications. PLoS One 2021;16:e0252976. [PMID: 34111200 DOI: 10.1371/journal.pone.0252976] [Reference Citation Analysis]
6 Su PY, Chen YY, Yen HH, Huang SP, Liu IL, Zeng YH, Hsu YC, Siao FY. Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus-A Hospital-Based Experience. J Clin Med 2021;10:2509. [PMID: 34204064 DOI: 10.3390/jcm10112509] [Reference Citation Analysis]
7 Daniel Moore J, Galbraith J, Humphries R, Havens JR. Prevalence of Hepatitis C Virus Infection Identified From Nontargeted Screening Among Adult Visitors in an Academic Appalachian Regional Emergency Department. Open Forum Infect Dis 2021;8:ofab374. [PMID: 34381848 DOI: 10.1093/ofid/ofab374] [Reference Citation Analysis]
8 Biondi MJ, Hirode G, Capraru C, Vanderhoff A, Karkada J, Wolfson-stofko B, Smookler D, Friedman SM, Bates K, Mazzulli T, Juan JV, Shah H, Hansen BE, Feld JJ, Janssen HL. Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario. CanLivJ. [DOI: 10.3138/canlivj-2021-0036] [Reference Citation Analysis]
9 Haukoos JS, Rowan SE, Galbraith JW, Rothman RE, Hsieh YH, Hopkins E, Houk RA, Toerper MF, Kamis KF, Morgan JR, Linas BP, Al-Tayyib AA, Gardner EM, Lyons MS, Sabel AL, White DAE, Wyles DL; DETECT Hep C Trials Investigators. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments. Trials 2022;23:354. [PMID: 35468807 DOI: 10.1186/s13063-022-06265-1] [Reference Citation Analysis]